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Abstract 47 
As the first marine teleost demonstrated to have the ability of long-chain polyunsaturated 48 
fatty acids (LC-PUFA) biosynthesis from C18 PUFA precursors, the rabbitfish Siganus 49 
canaliculatus provides us a unique model for clarifying the regulatory mechanisms of LC-PUFA 50 
biosynthesis in teleosts aiming at the replacement of dietary fish oil (rich in LC-PUFA) with 51 
vegetable oils (rich in C18 PUFA precursors but devoid of LC-PUFA). In the study of transcription 52 
regulation of gene encoding the Δ6Δ5 fatty acyl desaturase (Δ6Δ5 Fads), a rate-limiting enzyme 53 
catalyzing the first step of LC-PUFA biosynthesis in rabbitfish, a binding site for the transcription 54 
factor (TF), peroxisome proliferator-activated receptor γ (Pparγ), was predicted in Δ6Δ5 fads2 55 
promoter by bioinformatics analysis, and thus the present study focused on the regulatory roles of 56 
Pparγ on Δ6Δ5 fads2. First, the activity of the Δ6Δ5 fads2 promoter was proved to be 57 
down-regulated by pparγ overexpression and up-regulated by treatment of Pparγ antagonist 58 
(GW9662), respectively, in HEK 293T cells with the dual luciferase reporter assay. Pparγ was 59 
further confirmed to interact with the promoter by electrophoretic mobility shift assay. Moreover, 60 
in S. canaliculatus hepatocyte line (SCHL) cells, GW9662 decreased the expression of pparγ 61 
together with increase of Δ6Δ5 fads2 mRNA. Besides, Δ6Δ5 fads2 expression was increased by 62 
pparγ RNAi knock-down and reduced by its mRNA overexpression. Furthermore, knock-down of 63 
pparγ induced a high conversion of 18:3n−3 to 18:4n−3 and 18:2n−6 to 18:3n−6, while pparγ 64 
mRNA overexpression led to a lower conversion of that, and finally a significant decrease of 65 
20:4n-6(ARA), 20:5n-3(EPA) and 22:6n-3(DHA) production. The results indicate that Pparγ is 66 
involved in the transcriptional regulation of liver LC-PUFA biosynthesis by targeting Δ6Δ5 fads2 67 
in rabbitfish, which is the first report of Pparγ involvement in the regulation of LC-PUFA 68 
biosynthesis in teleosts. 69 
70 
Introduction 71 
Long-chain (≥C20) polyunsaturated fatty acids (LC-PUFA) such as eicosapentaenoic acid 72 
(EPA, 20:5n-3), docosahexaenoic acid (DHA, 22:6n-3) and arachidonic acid (ARA, 20:4n-6) are 73 
physiologically essential fatty acids (EFA) for vertebrates, playing important roles in gene 74 
regulation, signal transduction, lipogenesis and cell membrane fluidity (Benitezsantana et al., 2007, 75 
Schmitz and Ecker, 2008, Uauy et al., 2001, Galli et al., 1994). From a human nutrition standpoint, 76 
the so-called “omega-3” (n-3) LC-PUFA such as EPA and DHA have beneficial roles in a variety 77 
of human pathologies and disorders (Lorente-Cebrián et al., 2013). Fish, especially marine species, 78 
are major sources of n-3 LC-PUFA in the human diets. And, with over half of the production of 79 
fish now deriving from aquaculture, research aiming to understand LC-PUFA metabolism of fish 80 
farmed species has been driven to ensure the production of high quality (high n-3 LC-PUFA) 81 
products (Tocher, 2003). Traditionally, inclusion of high levels of marine ingredients such as 82 
fishmeal, but particularly fish oil (FO), in aquafeeds has delivered high n-3 LC-PUFA contents in 83 
farmed fish. However, there currently exists a tendency in the farming industry of some species 84 
such as the Atlantic salmon showing a reduction of n-3 LC-PUFA in the final product (Bell et al., 85 
2001). This is mostly due to the replacement of dietary FO by alternative oil sources such as 86 
vegetable oils (VO) since the latter are devoid of LC-PUFA and rather contain high levels of 87 
shorter-chain fatty acids (FA) such as the C18 polyunsaturated fatty acids (PUFA) linoleic acid (LA, 88 
18:2n-6) and α-linolenic acid (ALA, 18:3n-3) (Sargent et al., 2002). This problem can aggravate in 89 
fish species with limited capacity to convert C18 PUFA contained in dietary VO into LC-PUFA, 90 
thus compromising not only its nutritional value for the human consumer but also the dietary 91 
provision of essential nutrients for normal growth and development in captivity (Tocher, 2015). 92 
The ability of a certain vertebrate species to convert C18 PUFA into C20-22 LC-PUFA varies 93 
among species and depends upon the complement and function of two key enzymes, namely fatty 94 
acyl desaturases (Fads) and elongation of very long-chain fatty acid (Elovl) proteins (Castro et al., 95 
2016). Unlike mammals, teleost fish appear to possess only one type of fads-like genes in their 96 
genome, this being fads2 (Castro et al., 2012). Consistent with the mammalian FADS2, Fads2 97 
studied from many teleosts are also ∆6 desaturases but, interestingly, many teleost Fads2 have 98 
acquired other desaturase capabilities such as the bifunctional ∆6∆5 desaturases, monofunctional 99 
∆5 desaturases and ∆4 desaturases (Castro et al., 2016). Moreover, Elovl encoding genes with 100 
relevant roles in the biosynthesis of LC-PUFA in teleosts include Elovl2, Elovl4 and Elovl5, of 101 
which Elovl4 and Elovl5 are present in virtually all teleosts (Castro et al., 2016). Regulatory 102 
mechanisms controlling the expression of teleost fads and elovl have been investigated in order to 103 
understand the mechanisms underlying the response of fish to dietary components. With regards to 104 
fads2, transcriptional regulation by transcription factors (TF) such as sterol regulatory element 105 
binding proteins (Srebp), nuclear factor Y (NF-Y), liver X receptor (Lxr) and specificity protein 1 106 
(Sp1) have been establish for a range of species (Carmona-Antoñanzas et al., 2014, Geay et al., 107 
2012, Xu et al., 2014, Zheng et al., 2009). Particular progress on elucidating the mechanisms 108 
involved in fads2 regulation of teleosts has been made in rabbitfish S. canaliculatus, the first 109 
marine teleost demonstrated to have the ability of bioconverting C18 PUFA to LC-PUFA (Li et al., 110 
2010, Li et al., 2008, Monroig et al., 2012) and possessing two distinct Fads2 with Δ4 and Δ6Δ5 111 
desaturase capabilities (Li et al., 2010). Thus, the expression of the rabbitfish fads2 is controlled at 112 
transcriptional level by Lxr and Srebp1, regulating both Δ4 and Δ6Δ5 fads2 in rabbitfish liver 113 
(Zhang et al., 2016a), and by hepatocyte nuclear factor alpha (HNF4α) (Dong et al., 2016), 114 
specifically targeting Δ4 fads2 expression. Moreover, unique post-transcriptional regulatory 115 
mechanisms have been further established, with miR-17 exhibiting its action directly on Δ4 fads2 116 
(Zhang et al., 2014), and miR-33, whose more indirect action involves regulation of srebp1 117 
(Zhang et al., 2016b). 118 
Peroxisome proliferator-activated receptors (Ppar) play important roles in lipid metabolism 119 
(Desvergne et al., 2006, Poulsen et al., 2012, Tontonoz and Spiegelman, 2008)  and studies in 120 
fish have confirmed that Ppar regulate genes of fatty acid oxidation and deposition among other 121 
pathways (Leaver et al., 2008). In general, PPAR can be activated by natural or artificial ligands, 122 
then heterodimerized with retinoid X receptor (RXR), and subsequently bound to PPAR response 123 
element (PPRE) in target genes (Adeghate et al., 2011). Ppar protein family consists of three 124 
isotypes including PPARα, PPARβ (δ) and PPARγ. In mammals, PPARα is involved in stimulating 125 
fatty acid oxidation, PPARβ plays a role in the regulation of lipoprotein transport system 126 
(Desvergne et al., 2006), while PPARγ regulates glucose and lipid homeostasis, and induces lipid 127 
accumulation (Gurnell, 2005, Tontonoz and Spiegelman, 2008). With regards to specific actions 128 
within the LC-PUFA biosynthesis, PPARα, along with SREBP-1c, was demonstrated as an 129 
important TF in the feedback regulation of murine Fads2 (Matsuzaka et al., 2002), whereas 130 
PPARγ was inferred as a possible target for Lxr (Zhang et al., 2016a). Nevertheless, the 131 
mechanisms of transcriptional regulation by Pparγ on LC-PUFA biosynthesis in teleosts remain 132 
mostly unclear. 133 
Recently, three Ppar genes including pparα, pparβ (δ) and pparγ were cloned from rabbitfish, 134 
and the relatively high expression of pparα and pparγ in liver and intestine, major sites for 135 
LC-PUFA biosynthesis in fish (You et al., 2017), suggested potential regulatory roles in these 136 
pathways. Supplementation of the Ppar agonist fenofibrate to rabbitfish primary hepatocytes 137 
increased the expression of pparγ with depressed expression of Δ6Δ5 fads2, which indicated that 138 
Pparγ may have a regulation role on Δ6Δ5 fads2 (You et al., 2017). Moreover, preliminary 139 
investigations allowed us to identify a potential Pparγ binding site on Δ6Δ5 fads2 promoter. To 140 
further clarify the roles of Pparγ in the regulation of genes encoding pivotal enzymes within 141 
rabbitfish LC-PUFA biosynthesis, the present study investigated the transcription regulation of 142 
pparγ on Δ6Δ5 fads2 expression. First, the promoter activity of Δ6Δ5 fads2 was studied by 143 
overexpression pparγand supplementation of Pparγ antagonist (GW9662) in HEK 293T cells. 144 
Second, the gene expression pattern of pparγ and Δ6Δ5 fads2 was measured in S. canaliculatus 145 
hepatocyte line (SCHL) by mRNA overexpression or inhibition of pparγ. Furthermore, the 146 
capability of SCHL cells in bioconverting C18 PUFA to LC-PUFA was evaluated under pparγ 147 
overexpression or siRNA knock-down. These data will increase our knowledge of regulatory 148 
mechanisms of LC-PUFA biosynthesis in teleosts, and provide useful information for the 149 
successful replacement of VO in feeds for farmed fish. 150 
 151 
Materials and methods 152 
Cell lines and cell culture  153 
Human embryonic kidney (HEK 293T) cells (Chinese Type Culture Collection, Shanghai, 154 
China) were grown at 37 °C with 5 % CO2 concentration in high glucose Dulbecco's Modified 155 
Eagle Medium (DMEM) (GlutaMAX) (Gibco, Life Technologies, USA) supplemented with 10 % 156 
fetal bovine serum (FBS, Sijiqing Biological Engineering Material Company, Hangzhou, China). 157 
S. canaliculatus hepatocyte line (SCHL) recently established in our lab (Y et al., 2017) was grown 158 
at 28 °C using Dulbecco's modified Eagle's medium (DMEM)-F12 medium (Gibco) supplemented 159 
with 10% foetal bovine serum (FBS; Gibco) and 0.5 % rainbow trout Oncorhychus mykiss 160 
(Walbaum 1792) serum (Caisson Labs). 161 
 162 
Pparγ overexpression and detection of its influence on the Δ6Δ5 fads2 promoter activity 163 
A potential Pparγ binding site was predicted in the rabbitfish Δ6Δ5 fads2 promoter by using 164 
online software TRANSFAC® and JASPAR® (Fig. 1) (Dong et al., 2018). To confirm the effects 165 
of Pparγ on the Δ6Δ5 fads2 promoter activity, the overexpression vector pcDNA3.1-pparγ was 166 
constructed by cloning the rabbitfish pparγ open reading frame (ORF) (GenBank: JF502072.1) 167 
DNA fragment into the pcDNA3.1 vector (Invitrogen).  168 
The rabbitfish Δ6Δ5 fads2 promoter (2044 bp) was cloned from the Δ6Δ5 Fad mRNA of S. 169 
canaliculatus (GenBank: EF424276.2) (Dong et al., 2018). The promoter reporter vector was 170 
constructed with the Δ6Δ5 fads2 promoter fragment and pGL4.10, and the Δ6Δ5 fads2 Pparγ 171 
binding site-directed mutant of the Δ6Δ5 fads2 promoter was constructed with the mutation site in 172 
the middle of the primer. The promoter reporter vector contained the Firefly luciferase gene. 173 
Subsequently, the overexpression vector pcDNA3.1-pparγ was co-transfected with the Δ6Δ5 fads2 174 
promoter reporter vector into HEK 293T cells seeded in 96-well cell culture plates by 175 
Lipofectamine 2000 Reagent (Invitrogen, Carlsbad, CA, USA), and the content in transfection 176 
complex per well was listed as following: pcDNA3.1-pparγ (50 ng), Δ6Δ5 fads2 promoter (100ng) 177 
or Δ6Δ5 fads2 Pparγ site-directed mutant, internal control vector pGL4.75 (0.02 ng) and 178 
Lipofectamine 2000 Reagent (0.25 μL). The HEK 293T cell is a commercially available cell line 179 
commonly used for studying the promoter activity involving dual-luciferase reporter assays. After 180 
the cells were grown to about 80% confluency, the transfection assay was conducted. At 48 h 181 
post-transfection, the promoter activities were measured by Dual-Glo Luciferase Assay system 182 
(Promega, USA) according to manufacturer’s instructions. Specifically, 75 μl of Dual-Glo 183 
Luciferase Assay Reagent were added to each well, the plate was incubated at room temperature 184 
for 10 min. Then measure firefly luminescence on a Tecon microplate reader (Tecon, Switzerland), 185 
followed by the addition of Dual-Glo Stop & Glo Reagent to the plate and incubate at room 186 
temperature for 10 min. Finally, chemical luminescence intensity was detected in duplicate 187 
readings using a microplate reader (InfiniteM200 Pro, Tecan, Switzerland). The promoter activity 188 
was calculated by the ratio of luciferase to renilla intensity in each experiment well, and empty 189 
vector pGL4.10 was used as a negative control. 190 
 191 
Effect of Pparγ antagonist on the Δ6Δ5 fads2 promoter activity 192 
To detect the effects of a Pparγ antagonist (GW9662) on the Δ6Δ5 fads2 promoter activity, 193 
100 ng of Δ6Δ5 fads2 promoter reporter vector and 0.02 ng of pGL4.75 were co-transfected into 194 
HEK 293T cells. The transfection, done as the detailed above for the pparγ overexpression assay, 195 
lasted for 24 h, period after which the cell culture medium was replaced with DMEM + 10% FBS 196 
containing GW9662 at a final concentration of 20 μM or an equivalent volume of DMSO 197 
(concentration did not exceed 0.1 %, v/v). Then, 48 h post-transfection, the promoter activity was 198 
measured as the detailed above for the pparγ overexpression assay. 199 
 200 
Electrophoretic Mobility Shift Assay (EMSA) 201 
To further confirm the binding between Pparγ and the Δ6Δ5 fads2 promoter, primers were 202 
designed according to the Pparγ binding region in the Δ6Δ5 fads2 promoter and 5’-biotin labeled 203 
for production of EMSA probes (Table 1). The experimental probe was produced in a 100 μL 204 
annealing reaction system including 40 μL nuclease-free water, 40 μL annealing buffer for DNA 205 
Oligos (5X) (Beyotime, China), 20 μL primer F for EMSA (50 μM), 20 μL primer R for EMSA 206 
(50 μM). The extraction of nuclear protein from the rabbitfish hepatocytes was conducted using 207 
Nuclear and Cytoplasmic Protein Extraction Kit (Beyotime, China) according to the 208 
manufacturer’s instructions. For the binding reaction, 6 μg of nuclear protein were incubated in a 209 
total volume of 10 μL with binding buffer containing 2 μL of biotin labeled probe (BP) (0.1 pM). 210 
Competing reaction and cold competing reaction were performed using a 100-fold excess of 211 
unlabeled probe (UP) and unlabeled mutant probe (UTP). The reaction was carried out in lane 1 212 
(no proteins, 5′ biotin labeled probe), lane 2 (rabbitfish hepatocyte nucleus proteins, 5′ biotin 213 
labeled free probe), lane 3 (rabbitfish hepatocyte nucleus proteins, unlabeled competitor probe, 5′ 214 
biotin labeled free probe), lane 4 (rabbitfish hepatocyte nucleus proteins, unlabeled mutant 215 
competitor probe, 5′ biotin labeled free probe). Following addition of 2 μL sample buffer, the 216 
protein-DNA complexes were resolved on a 4 % non-denaturing polyacrylamide gel in 0.5×TBE 217 
buffer at 380 mA for 1 h and then transferred to nylon membrane. Finally, biotin-labeled DNA was 218 
detected by chemiluminescence using the Chemiluminescent EMSA Kit (Beyotime, China) 219 
according to manufacturer’s protocol. 220 
 221 
Effect of Pparγ antagonist on Δ6Δ5 fads2 gene expression in SCHL cells 222 
To determine the effects of Pparγ antagonist on Δ6Δ5 fads2 gene expression, the SCHL cells 223 
were seeded in 6-well plates at a density of 2 × 106 cells per well and cultured for 24 h. Then the 224 
medium was replaced with fresh DMEM + 10% FBS in addition of GW9662 with a final 225 
concentration of 20 μM. The control group was treated with the same volume of medium without 226 
GW9662. All treatments were run in triplicate wells. After 48 h incubation, the cells were 227 
collected and lysed for RNA isolation under the instructions of TriPure RNA Isolation Reagent 228 
(Roche). 229 
 230 
Effect of siRNA on pparγ and Δ6Δ5 fads2 gene expression in SCHL cells 231 
To further clarify the influence of Pparγ on Δ6Δ5 fads2 regulation, an RNAi fragment 232 
targeting the rabbitfish Pparγ was run by transfection into SCHL cells (Lipofectamine 2000, 233 
Invitrogen). The siRNA sequence included seq 1 (5’-CCUCCCAAACAGUCAGAUUTT-3’) and 234 
seq 2 (5’-UUCUCCGAACGUGUCACGUTT-3’), seq 1 was 884 bp to ATG and set as experiment 235 
group, while seq 2 was negative control. The siRNA (0.2 nmol) was transfected into the SCHL 236 
cells after 24 h incubation, after 24 h transfection, the cells were collected and lysed for RNA and 237 
lipid extraction.  The survival rate of the cells was more than 95 % over the course of the whole 238 
operation. 239 
 240 
Influence of pparγ mRNA overexpression on Δ6Δ5 fads2 gene expression in SCHL cells 241 
The influence of Pparγ on Δ6Δ5 fads2 expression was further established by running an 242 
mRNA overexpression assay performed by transfecting pparγ mature transcripts into SCHL cells. 243 
mRNA transcription was performed on a linearized DNA template containing T7 promoter, pparγ 244 
ORF (GenBank: JF502072.1) using mMESSAGE mMACHINE T7 Ultra Kit (Ambion, Austin, 245 
TX, USA) according to the manufacturer to generate capped mRNA with a poly(A) tail. Plasmid 246 
pcDNA3.1-pparγ was used as a template for a linearized DNA template above with T7 promoter 247 
primer and antisense primer of pparγ containing termination codon in a pfu-PCR reaction (Table 248 
1). Finally, the mRNA product was purified with MEGA clear TM Kit (Ambion), and stored in 249 
-80°C for further transfection into cell line. The method of rabbitfish SCHL cell culture was the 250 
same with antagonist assay above. When the cells were grown to 80% confluence for 24 h, a 251 
transfection complex consisting of 2 μg pparγ mRNA and 6.25 μL LipofectamineTM 252 
Messenger-MAXTM Reagent (Invitrogen) were transfected into cells within well. At 48 h after 253 
transfection, cells were lysed and harvested for RNA and lipid extraction (see subsequent section 254 
for methodological details). The survival rate of the cells was more than 90 % over the course of 255 
the entire operation. 256 
 257 
Quantitative real-time PCR analysis 258 
The expression of pparγ and Δ6Δ5 fads2 from experiments involving SCHL cells was 259 
analyzed by quantitative real-time PCR analysis (qPCR). Total RNA was extracted using TRIzol® 260 
Reagent (Invitrogen, USA). Total RNA (1 μg) was reverse-transcribed into cDNA with FastKing 261 
RT Kit including gDNase treatment (Tiangen, China). Primers used for qPCR were listed in Table 262 
1. The relative gene expression of pparγ and Δ6Δ5 fads2 was normalized with that of 18S rRNA 263 
(GenBank: AB276993) with the 2−ΔΔCt method (Livak and Schmittgen, 2001). Each qPCR (total 264 
volume of 20 μL) consisted of 2 μL diluted cDNA (10 ng/μL), 0.5 μM of each primer and 10 μL 265 
SYBR Green I Master (Roche), and reactions were carried out on a Lightcycler 480 system 266 
(Roche, Switzerland). No template controls (NTC) were run systematically in each plate as 267 
negative controls. The qPCR program consisted of an initial activation step at 95 °C for 5 min, 268 
followed by 35 cycles of 10 s at 95 °C, 20 s at 60 °C and 20 s at 72 °C. After the amplification, 269 
dissociation curves of 0.5 °C increments from 65 °C to 95 °C were carried out to confirm the 270 
amplification of a single product in each reaction. 271 
 272 
Lipid extraction and fatty acid analysis  273 
The cells were digested with Trypsin-EDTA (Invitrogen) and centrifuged at 4000 ×g for 5 274 
min. Fatty acids were extracted from the cells precipitate by steeping in 2 ml chloroform/methanol 275 
(2:1 v/v), then 0.5 N methanolic KOH and 14 % boron trifluoride–methanol (Sigma-Aldrich, USA) 276 
were used to saponify the FA for fatty acid methyl ester (FAME) (Wijngaarden, 1967) derivative. 277 
Finally, FAME were separated and quantified by GC-2010 Plus gas chromatograph (Shimadzu, 278 
Japan) as we described before (Li et al., 2008). 279 
 280 
Statistical analysis 281 
All data for dual luciferase assays, gene expression and FA contents were presented as mean 282 
± SEM (n=3). The differences among the groups were analyzed with one-way analysis of variance 283 
(ANOVA) followed by Tukey's multiple comparison test or Student's t-test (as indicated) using 284 
Origin 7.0. Differences were considered significant at P < 0.05 to all statistical tests performed. 285 
 286 
Results 287 
pparγ overexpression decreased the activity of rabbitfish Δ6Δ5 fads2 promoter  288 
HEK 293T cells co-transfected with the overexpression vector pcDNA3.1-pparγ and Δ6Δ5 289 
fads2 promoter showed a significant decrease of Δ6Δ5 fads2 promoter activity, while Δ6Δ5 fads2 290 
promoter with ppre mutant had no response to pparγ overexpression (Fig. 2). No response to the 291 
pparγ overexpression was observed in the negative control (pGL4.10). This result was in 292 
agreement with our hypothesis that ppre site within the Δ6Δ5 fads2 promoter is the target site for 293 
Pparγ. 294 
 295 
Pparγ antagonist GW9662 increased the activity of rabbitfish Δ6Δ5 fads2 promoter 296 
To further confirm the action of Pparγ on Δ6Δ5 fads2 promoter, the effects of the Pparγ 297 
antagonist GW9662 was tested. Thus, HEK 293T cells transfected with the rabbitfish Δ6Δ5 fads2 298 
promoter and treated with Pparγ antagonist GW9662 showed a significant increase of the Δ6Δ5 299 
fads2 promoter activity. On the contrary, the ppre mutant and the control pGL4.10 exhibited no 300 
change when treated with GW9662 (Fig. 3). These data further suggested that Pparγ is a negative 301 
regulator targeting the rabbitfish Δ6Δ5 fads2 promoter.  302 
 303 
Pparγ interacted with the TF binding site in the Δ6Δ5 fads2 promoter  304 
Electrophoretic Mobility Shift Assay was performed with rabbitfish hepatocyte nucleus proteins 305 
(Fig. 4). No gel shift band was observed in lane 1 (no protein). Nevertheless, a gel shift band was 306 
observed in lane 2 containing rabbitfish hepatocyte nucleus proteins and 5′ biotin labeled probe, 307 
while unlabeled competitor probe could compete with the binding reaction (lane 3) and unlabeled 308 
mutant competitor probe could not compete in the reaction (lane 4). The results confirmed the 309 
interaction between Pparγ and the Δ6Δ5 fads2 promoter binding region. 310 
 311 
Pparγ antagonist GW9662 down-regulated the expression of pparγ and up-regulated that of Δ6Δ5 312 
fads2 313 
Using SCHL cells, the effect of Pparγ antagonist GW9662 on the expression of pparγ and 314 
Δ6Δ5 fads2 was investigated. The results showed that, compared to controls, the mRNA level of 315 
pparγ was significantly decreased when SCHL cells were treated with GW9662, while that of 316 
Δ6Δ5 fads2 was significantly increased (Fig. 5a). These results indicated a negative regulatory 317 
role of Pparγ on gene expression of Δ6Δ5 fads2 in rabbitfish hepatocytes. 318 
 319 
siRNA of pparγ induced the expression of Δ6Δ5 fads2 in SCHL cells 320 
An experiment using RNAi of pparγ was conducted to confirm the functional relationship 321 
between Pparγ and Δ6Δ5 fads2 at transcription level. The results showed that, compared with the 322 
control group, siRNA of pparγ significantly decreased the pparγ mRNA level (70.2 ± 6.8 % 323 
decrease). Moreover, the levels of Δ6Δ5 fads2 mRNA were significantly increased (155 ± 14.6 %) 324 
(Fig. 5b). These results are consistent with the those with the Pparγ antagonist assay indicating 325 
that Pparγ is a negative regulator of rabbitfish Δ6Δ5 fads2. 326 
 327 
pparγ mRNA overexpression decreased the mRNA expression of Δ6Δ5 fads2 in SCHL cells 328 
The inhibition of Pparγ (GW9662 treatment and RNAi) was accompanied with an 329 
up-regulation of rabbitfish Δ6Δ5 fads2 expression in SCHL cells, and the influence of pparγ 330 
overexpression to the possible target gene expression was identified by mRNA transfection into 331 
hepatocyte. Compared to the control group, pparγ mRNA in SCHL cells overexpressing pparγ 332 
increased between 400 to 500 fold, whereas the Δ6Δ5 fads2 mRNA decreased to 33.1 ± 14.0 % 333 
(Fig. 5c). The results clearly show that Δ6Δ5 fads2 transcription is down-regulated under pparγ 334 
overexpression, thus proving its role as a negative regulator to Δ6Δ5 fads2. 335 
 336 
Overexpression of pparγ decreased while siRNA of pparγ increased the enzymatic activity of Δ6Δ5 337 
Fads in SCHL cells 338 
The impact of Pparγ on the desaturase activity was determined by analyzing the FA profiles 339 
of SCHL cells treated with pparγ overexpression (Table 2). FA ratios of desaturation 340 
products/substrates such as 18:3n−6/18:2n−6 and 18:4n−3/18:3n−3 was increased with 341 
knock-down of pparγ, but decreased with overexpression of pparγ, indicating a change of Δ6Δ5 342 
Fad desaturation activity. Besides, the level of total LC-PUFA (ΣLC-PUFA) was significantly 343 
decreased in cells treated with overexpressing pparγ, and the level of FA precursor 18:3n-3 (ALA) 344 
was significantly higher, compared with those in control. Overall, the FA results clearly indicated 345 
that Pparγ impacted the LC-PUFA biosynthesis by reducing the desaturase capacity. 346 
 347 
Discussion 348 
The present study investigated the role of Pparγ in the regulation of Δ6Δ5 fads2, a gene 349 
encoding a fatty acyl desaturase with key roles in the LC-PUFA biosynthesis in rabbitfish. Results 350 
from a set of experiments using HEK 293T cells showed that both pparγ overexpression or a 351 
Pparγ antagonist (GW9662) treatment affected the activity of the Δ6Δ5 fads2 promoter, and 352 
EMSA confirmed that Pparγ interacted with the promoter, suggesting a role for Pparγ in Δ6Δ5 353 
fads2 regulation. Such role of Pparγ as Δ6Δ5 fads2 modulator was further confirmed at 354 
transcriptional level in SCHL cells using a varied range of methodological approaches including 355 
GW9662 treatment, pparγ targeted siRNA, and pparγ overexpression. Finally, the effects of Pparγ 356 
on the LC-PUFA biosynthetic pathways were estimated by determining the changes produced in 357 
the FA profiles of SCHL cells overexpressing the rabbitfish pparγ. Overall our data strongly 358 
suggested that Pparγ acted as a negative regulator on Δ6Δ5 fads2 expression in rabbitfish.  359 
PPARγ is a key inducer of differentiation, lipogenesis, and insulin sensitivity in white and 360 
brown adipocytes and is involved in lipid deposition in many other cell types (Poulsen et al., 361 
2012). The previous study in human skeletal muscle tissue speculated that PPARγ might be a 362 
positive regulator for carnitine palmitoyl transferase-1 (CPT-1), lipoprotein lipase (LPL) and fatty 363 
acid binding protein (FABP) (Lapsys et al., 2000). PPARγ play an important role in modulating 364 
lipid accumulation (Auwerx, 1999), and is activated by many FA (Forman et al., 1996). In Atlantic 365 
salmon (Salmo salar), Ppar was demonstrated to be an important factor in mediating enzymatic 366 
response to fibrates (Ruyter et al., 1997). A previous study reported that troglitazone (a PPARγ 367 
agonist) induced an increase in PPARγ and a decrease in FADS2 (∆6 desaturase) expression in 368 
human skeletal muscle cells, speculating that there is a PPRE element in FADS2 promoter (Wahl 369 
et al., 2002). However, another study demonstrated that the PPRE imparted PPARα responsiveness 370 
to the human FADS2 promoter, but not PPARγ (Tang et al., 2003). These data indicated that the 371 
effects of PPARs on human FADS2 expression in skeletal muscle cells may similar to the situation 372 
as demonstrated in rabbitfish. 373 
In rabbitfish, Ppar cDNAs were cloned and characterized their tissue distribution, PPARα 374 
was widely expressed in tissues and was particularly abundant in the heart, brain and liver, PPARβ 375 
expression is considerably higher in the gills than in the other tissues, PPARγ was predominantly 376 
expressed in the intestine, gills and liver (You et al., 2017), indicating that PPARα and PPARγ 377 
were potential candidates involved in the regulation of LC-PUFA biosynthesis in rabbitfish. In the 378 
present study, a potential Pparγ binding site (ppre located at +51 bp to TSS) was found on the 379 
Δ6Δ5 fads2 promoter. The Δ6Δ5 fads2 promoter activity increased significantly after treated with 380 
GW9662, which was a potent and selective antagonist of PPARγ and showed no effect on 381 
transcription on PPARα and PPARσ (Leesnitzer et al., 2002), and decreased significantly after 382 
treated with overexpression of pparγ, while ppre mutant did not response to GW9662 and 383 
overexpression of pparγ. Mutation of ppre resulted in significantly decreased transcriptional 384 
activity, which suggested that this TF binding site was important for maintaining Δ6Δ5 fads2 385 
promoter activity. In rat liver, PPARγ, along with PPARα, interacted with a PPRE located inthe the 386 
promoter of lipoprotein lipase (lpl) (Schoonjans et al., 1996). In rabbitfish primary hepatocytes, 387 
pparα expression was depressed in response to supplementation of Pparγ-specific agonist 388 
15-deoxy-D12,14-prostaglandin J2 (15d-J2), in agreement with the depression of rabbitfish Δ6Δ5 389 
fads2 expression (You et al., 2017). Hence, it was worth considering that whether there was 390 
PPARα binding site on the Δ6Δ5 fads2 promoter, the mechanism for concomitant activation of 391 
rabbitfish PPARα and Δ6Δ5 Fads should be further investigated. 392 
The studies in SCHL cells further confirmed that Δ6Δ5 fads2 is regulated by Pparγ since the 393 
expression of Δ6Δ5 fads2 was regulated by each treatment of Pparγ. Previous study in European 394 
seabass (Dicentrarchus labrax) demonstrated the concomitant increase of ppar and Δ6 fads2 395 
mRNA levels induced by dietary n-3 LC-UFA deficiency, suggested a potential role of Ppar 396 
members in the regulation of Δ6 fads2 in this species (Vagner et al., 2009). However, when the 397 
Atlantic salmon SHK-1 cells were incubated with Ppar agonists (WY14643 and 398 
2-bromopalmitate), there were no significant change in the expression of Ppar encoding genes 399 
(Carmona-Antoñanzas et al., 2014). In rabbitfish primary hepatocytes, the PPAR agonist 400 
(Fenofibrate) induced pparγ expression, and meanwhile suppressed the expression of Δ6Δ5 fads2, 401 
which suggested a possible regulation of Pparγ on Δ6Δ5 fads2 (You et al., 2017). These results 402 
suggested that PPARγ may have different regulatory mechanism in different species. In the present 403 
study in SCHL cells, the Pparγ antagonist GW9662 increased the expression of Δ6Δ5 fads2, 404 
coinciding with the suppression of Pparγ antagonists, suggesting the role of Δ6Δ5 fads2 as the 405 
downstream gene of Pparγ. This was further confirmed by the function assay of Pparγ on Δ6Δ5 406 
fads2 expression such as the pparγ overexpression and knockdown in SCHL cells.  407 
The regulation of Δ6Δ5 fads2 by Pparγ will eventually lead to altered FA profiles, 408 
particularly those that are desaturation substrates or products. Previously, a study on human 409 
skeletal muscle cells treatedwith troglitazone exhibited changes in unsaturated FA profiles despite 410 
the decrease of Δ6 fads mRNA levels (Wahl et al., 2002). In rabbitfish, functional characterization 411 
show that Δ6/Δ5 Fads could efficiently convert 18:3n-3 and 18:2n-6 to 18:4n-3 and 18:3n-6, 412 
resperctively (Li et al., 2010). The ratio of C18:3n-6/C18:2n-6 could be an index of Δ6 Fads 413 
activity (Borkman et al., 1993). In the present study, remarkable changes of the FA profiles were 414 
detected in SCHL cells overexpressing and knock-down pparγ mostly associated with decreased 415 
and increased levels of the direct Δ6 desaturation products such as 18:4n-3 and 18:3n-6, or further 416 
downstream products within the LC-PUFA biosynthetic pathways such as EPA and DHA. We 417 
showed that RNAi knockdown of pparγ caused an increase in 18:4n−3/18:3n−3 and 418 
overexpression of pparγ caused a decrease in 18:4n−3/18:3n−3, and 18:3n−6/18:2n−6 in rabbitfish 419 
hepatocyte cells, which indicates an increase and a decrease in Δ6Δ5 Fads enzymatic activity. And 420 
in pparγ mRNA overexpression assay, the ratio of 18:4n−3/18:3n−3 was higher than the ratio of 421 
18:3n−6/18:2n−6 in the control group, suggested that rabbitfish Δ6Δ5 Fads tend to convert n-3 422 
PUFA. This result correspond to the previous study that dietary linoleic ( 18:2n−6) and α-linolenic 423 
acids (18:3n−3) may promote the expression of Δ6 desaturase, the promoting action of α-linolenic 424 
acid on Δ6 desaturase gene expression is stronger than that of linoleic acid in S. canaliculatus (Li 425 
et al., 2010). Moreover, there were significantly lower contents of EPA, DHA, ARA and higher 426 
contents of ALA in pparγ mRNA overexpression group, whereas the contents of LA, showed no 427 
significant difference, when compared to control group, indicating that Pparγ has a more 428 
significant effect on enzymatic activity of Δ6Δ5 Fads involved in n-3 pathway than that in n-6 429 
pathway. As Pparγ could be activated by fatty acids at physiological concentrations (Gearing et al., 430 
1994), this could be the underlying molecular mechanism whereby dietary lipids affect LC-PUFA 431 
synthesis through Pparγ. 432 
In summary, the present study demonstrated that Pparγ negatively influences the biosynthesis 433 
of LC-PUFA by targeting Δ6Δ5 fads in rabbitfish liver, which was the first report of Pparγ 434 
involved in regulation of LC-PUFA biosynthesis in teleosts, may contribute to the exploration of 435 
enhancing LC-PUFA biosynthesis in fish. 436 
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577 
Table 1.  578 
Primers used for gene clone, EMSA, qPCR or vector construction. 579 
Aim  Gene/vector name Primers/oligo nucleotides  Nucleotide sequence 
Vector reconstruction pcDNA3.1- pparγ pparγ-F 5′-CCCGAATTCATGTGTCCTCCCTGTCGCC-3′ 
  pparγ-R 5′-CCCTCTAGATCCCACTTGTTTCCCTCCTTGC-3′ 
pparγ mRNA construction pparγ T7 promoter primer 5′-TAATACGACTCACTATAGGG-3′ 
  pparγ-R 5′-CCCTCTAGATCCCACTTGTTTCCCTCCTTGC-3′ 
EMSA probes  pparγ BPF (5’-biotin labeled) 5′-GGAGCACGGTCAACGTGACCATAGGAA-3′ 
  BPR (5’-biotin labeled) 5′-TTCCTATGGTCACGTTGACCGTGCTCC-3′ 
  UPF 5′-GGAGCACGGTCAACGTGACCATAGGAA-3′ 
  UPR 5′-TTCCTATGGTCACGTTGACCGTGCTCC-3′ 
  UTPF 5′-GGAGCACTTTCGACGGGAAAATAGGAA-3′ 
  UTPR 5′-TTCCTATTTTCCCGTCGAAAGTGCTCC-3′ 
qPCR pparγ qPCR-pparγ-F 5′-CTGCTGGCTGAGTTCTCGTCT-3′ 
  qPCR-pparγ-R 5′-ATGACAAAAGGCGCGTTATCTC-3′ 
 Δ6Δ5 fads2 qPCR-Δ6Δ5 fads2-F 5′-TCACTGGAACCTGCCCACAT-3′ 
  qPCR-Δ6Δ5 fads2-R 5′-TTCATTCTCAGACAGTGCAAACAG-3′ 
 18S rRNA qPCR-18S-F 5′-CGCCGAGAAGACGATCAAAC-3′ 
  qPCR-18S-R 5′-TGATCCTTCCGCAGGTTCAC-3′ 
 580 
581 
Table 2. 582 
Fatty acid composition (% total fatty acids) of Siganus canaliculatus hepatocyte line (SCHL) cells 583 
transfected with pparγ siRNA or pparγ mRNA.  584 
Notes: Values are means ± SEM from three treatments (n = 3). In the treatment of Knock-down of 585 
pparγ or overexpression of pparγ, different superscripts in the same rows indicate significant 586 
difference at P < 0.05 by Student's t-test. SFA, saturated fatty acids; MUFA, monounsaturated 587 




Knock-down of pparγ  Overexpression of pparγ 
Negative 
control  
pparγ siRNA  Control pparγ mRNA 
14:0 0.43±0.06  0.50±0.02   1.79±0.15  1.86±0.66  
16:0 16.81±0.77  15.17±0.47   16.43±0.07  18.83±0.83  
18:0 13.65±0.51  13.57±0.93   18.38±0.61  23.22±0.59  
22:0 1.55±0.12  1.54±0.16   1.94±0.23  1.44±0.24  
16:1n-7 4.54±0.19  5.08±0.55   2.42±0.13  2.67±0.23  
18:1n-9 31.87±0.73  31.38±2.12   23.93±0.55  23.37±1.77  
20:1n-9 0.72±0.04  0.71±0.04   0.95±0.19  0.51±0.09  
24:1 0.32±0.13  0.33±0.02   1.45±0.09  1.29±0.08  
18:2n-6(LA) 3.77±0.11  3.78±0.17   2.65±0.07  2.32±0.44  
20:2n-6 0.90±0.08  0.82±0.08   0.38±0.03  0.90±0.34  
18:3n-6 0.59±0.17b 1.53±0.35a   1.09±0.17a  0.49±0.15b  
18:3n-3(ALA) 0.62±0.21  0.65±0.04   0.72±0.21b  2.81±0.99a  
18:4n-3 0.32±0.05b  0.88±0.18a   0.51±0.07a  0.29±0.06b  
20:4n-6(ARA) 4.84±0.51  4.73±0.73   7.50±0.16a 5.98±0.34b  
20:5n-3(EPA) 3.17±0.10  3.22±0.25   3.50±0.09a  2.87±0.21b  
22:6n-3(DHA) 16.09±1.33  16.12±1.09   16.35±0.15a  11.09±1.80b  
ΣSFA 32.45±0.15  30.78±1.36   38.53±0.31  45.35±1.63  
ΣMUFA 37.45±0.77  37.49±2.51   28.76±0.44  27.83±2.00  
ΣPUFA 30.28±0.69 31.73±1.17  32.71±0.44 26.76±2.45 
ΣLC-PUFA 24.09±0.79  24.07±1.64   27.35±0.40a  19.94±1.27b  
18:3n-6/18:2n-6 0.16±0.04b  0.41±0.10a   0.41±0.07a  0.21±0.02b  
18:4n-3/18:3n-3 0.54±0.16b  1.36±0.31a   0.75±0.26a  0.12±0.06b  
Figure Legends 591 
Fig. 1. The nucleotide sequence and predicted binding sites for Pparγ in the core region of the 592 
rabbitfish Δ6Δ5 fads2 promoter. Numbers are given relative to the first base of the transcription 593 
start site (TSS). Potential transcription binding motif for Pparγ is marked in grey (Dong et al., 594 
2018). 595 
 596 
Fig. 2. Effects of Siganus canaliculatus pparγ overexpression on activity of Δ6Δ5 fads2 promoter. 597 
HEK 293T cells were co-transfected with the Δ6Δ5 fads2 promoter vector and the overexpression 598 
vector pcDNA3.1-pparγ or the empty vector pcDNA3.1 (control). The negative control (pGL4.10) 599 
was an empty vector with no promoter sequence upstream in the reporter gene. Δ6Δ5 600 
fads2-mutant was Δ6Δ5 fads2 - Pparγ site-directed mutant. Y-axis is the Firefly/Renilla luciferase 601 
ratio, while x-axis stands for different reporter vector. Data are means ± SEM (n = 3) and asterisks 602 
represent significant differences (Student’s t-test; P < 0.05). 603 
 604 
Fig. 3. Effects of the Pparγ antagonist GW9662 on activity of the Δ6Δ5 fads2 promoter. HEK 605 
293T cells transfected with the Δ6Δ5 fads2 promoter were treated with or without (control) 606 
GW9662. The negative control (pGL4.10) was an empty vector with no promoter sequence 607 
upstream in the reporter gene. Δ6Δ5 fads2-mutant was Δ6Δ5 fads2-Pparγ site-directed mutant. 608 
Y-axis is the Firefly/Renilla luciferase ratio, while x-axis stands for different reporter vector. Data 609 
are shown as means ± SEM (n = 3) and asterisks represent significant differences (Student’s t-test; 610 
P < 0.05). 611 
 612 
Fig.4. Electrophoretic mobility shift assay (EMSA) of TF binding site in the Δ6Δ5 fads2 promoter 613 
with rabbitfish hepatocytes nucleus proteins. Lane 1, negative control; Lane 2, nucleus proteins 614 
reactions; Lane 3, unlabeled probe competing reactions; Lane 4, unlabeled mutant probe 615 
competing reactions. BP, biotin labeled probe; UP, unlabeled probe; UTP, unlabeled mutant 616 
probe. 617 
 618 
Fig.5. Q-PCR analyses of pparγ and Δ6Δ5 fads2 expression in Siganus canaliculatus hepatocyte 619 
line (SCHL) cells, (a) treated with the Pparγ antagonist GW9662, (b) transfected with pparγ 620 
siRNA, (c) transfected with pparγ mRNA. Relative expression of the target genes in SCHL cells 621 
was quantified for each transcript and was normalized with the expression of 18S rRNA by 2− ΔΔCt 622 
method. Results are means ± SEM (n=3) and asterisks indicate significant differences of gene 623 
expression between the control and the GW9662 treatment (Student’s t-test; P < 0.05). 624 
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